Additionally, dry skin, erythema, hyperhidrosis, pruritus, and rash were frequently associated with AI-related skin impairments, emphasizing the necessity for concurrent protective strategies during AI treatment in BC patients
GLP-1 Receptor Agonist Market Segmentation By Product Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Victoza Zepbound Other Products By Application Type 2 Diabetes Mellitus Obesity By Route of Administration Parenteral Oral By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Region North America US Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at [email protected] Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership
New Research Into How Oral GLP-1s Act in the Brain A study published in the journal Nature on 6 May 2026 offered a further dimension to the oral versus injectable debate
Both studies showed a lower incidence of growth-restricted babies in the lycopene group
Contact us for a free consultation or use the chatbot on this page to see if you qualify for legal action instantly
